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Background
Psychotherapy can alleviate mental distress and improve quality
of life, but little is known about its potential negative effects and
how to determine their frequency.
Aims
To present a commentary on the current understanding and
future research directions of negative effects in psychotherapy.
Method
An anonymous survey was distributed to a select group of
researchers, using an analytical framework known as strengths,
weaknesses, opportunities and threats.
Results
The researchers perceive an increased awareness of negative
effects in psychotherapy in recent years, but also discuss some
of the unresolved issues in relation to their definition, assess-
ment and reporting. Qualitativemethods and naturalistic designs
are regarded as important to pursue, although a number of
obstacles to using such methods are identified.
Conclusion
Negative effects of psychotherapy are multifaceted, warranting
careful considerations in order for them to be monitored and
reported in research settings and routine care.
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Psychotherapy has the potential of alleviating mental distress and
improving quality of life for many patients. However, despite prom-
ising research results and an increased dissemination of effective
treatments, little is known about their potential negative effects.
Possible harmful events have been explored, both in terms of deteri-
oration of symptomatology and adverse and unwanted events, but
more needs to be done with respect to understanding, monitoring
and reporting their incidents. This article discusses some of the
current findings and future challenges with regard to investigating
and reporting negative effects of psychotherapy.
Negative effects belong to a relatively unchartered territory of psy-
chotherapy research, as little attention has been given to the possibil-
ity that some patients might deteriorate or experience adverse or
unwanted events during treatment.1 Two recent editorials and a
cross-sectional survey published in the British Journal of Psychiatry
have recognised the need for further study of negative effects, and
provided empirical evidence of their incidence among patients receiv-
ing psychological treatment through the National Health Service in
the UK.2–4 In total, 5.2% of the respondents stated that they had
experienced lasting negative effects, and findings indicated that the
odds of such events were higher among minority groups and those
who were uncertain about what type of treatment they had received.
Recommendations on how to advance the research on negative effects
were also put forward, such as, the use of a more coherent termin-
ology, clearer procedures for monitoring and reporting negative
effects, and notifying patients of the potential risks of treatment
during the informed consent process.
We sought to address these recommendations by administering
a survey to a select group of researchers in the field of psychother-
apy. The aim was to provide an overview of expert perceptions of
what is known of the occurrence and characteristics of negative
effects and how well they are currently being studied. In addition,
the purpose was to summarise expert recommendations regarding
strategies to better understand and investigate negative effects, pri-
marily in a research setting. In so doing, this studymay contribute to
efforts in raising awareness of such events among researchers and
clinicians, improve their monitoring and reporting in routine care
and research settings, and shed some light on the complex nature
of exploring negative effects in psychotherapy.
Method
A select group of researchers in the field of psychotherapy were
invited to share their perspective on the topic of negative effects.
These were chosen on the basis of prior experience in psychotherapy
research, in particular, investigating events that can be considered
harmful, for example deterioration, either through prior publica-
tions or reputation. In this sense, the recruitment to the group
can be regarded as convenience sampling. Of the ten researchers
that were invited, two declined participation because of time con-
straints, and one did not respond despite several reminders.
Hence, included in the commentary were seven respondents; two
women and five men, with three being from Sweden, one from
the UK and three from the USA. Given that no patient data was
included, no ethics approval was warranted.
A survey was administered online using an analytical frame-
work known as strengths, weaknesses, opportunities and threats
(SWOT). Pickton & Wright5 described this as ‘the collection and
portrayal of information about internal and external factors which
have, or may have, an impact on business’, that is, identifying the
resources, limitations, possibilities and risks of a particular area of
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interest. Most often, SWOT is applied in organisational or financial
settings to enhance creativity and predict upcoming competition.
However, this framework can also be used in domains unrelated to
any commercial interest, such as, determining the usefulness and
drawbacks of a new intervention, for example virtual reality
therapy.6 The researchers were thus encouraged to give their
opinion on how the investigation of negative effects in psychotherapy
is being performed and might be enhanced, using the guidelines in
SWOT to facilitate a discussion (see the Appendix). The survey was
completely anonymously in order to reduce risk of conformity and
social inhibition. A.R. then compiled a summary that was sent out
to everyone involved in order for them to comment on each other’s
responses, also anonymously. The responses were examined themat-
ically to derive recurrent themes. Finally, a draft of the results was pre-
pared and examined by the researchers before being submitted for
potential publication. This permitted the provision of additional
information throughout the process and allowed revisions to be
made in relation to previous statements. A similar approach has
been applied for developing a consensus of monitoring and reporting
negative effects in psychotherapy delivered via the internet.7
In the current commentary, the term negative effects is used to
describe potentially harmful events more globally, as proposed by
Hadley & Strupp,8 that is, including not only deterioration in symp-
tomatology, but also other potential adverse and unwanted events.
Meanwhile, deterioration refers to the change between two points
of measurement in a negative direction, which is often determined
using the Reliable Change Index (RCI).9 Adverse and unwanted
events are used to describe those situations where the patient experi-
ences an unforeseen and undesirable effect, which does not have to
be associated with increased symptomatology, for example novel
symptoms and stigma.10
Results
Strengths
Greater awareness of negative effects
The awareness of patients experiencing negative effects in psychother-
apy is believed to have improved during the past decade. In particular,
clinicians and researchers have becomemoremindful of the fact that a
proportion of patients deteriorate during treatment, and that there are
reliablemethods to detect andmonitor patients where improvement is
absent. However, it is clear that clinical training rarely includes infor-
mation about negative effects,11 and that researchers seldom report
negative effects in clinical trials.12 Also, the use of practices for asses-
sing deterioration is still missing in most contexts, despite evidence
suggesting that the rate of deterioration can be reduced from 23.2 to
15.2% just by using between-session monitoring,13 and be as low as
8.5% by also providing the clinician with tools for problem-
solving.14 Moreover, reporting negative effects of psychotherapy is
still not mandatory in most scientific journals, making it difficult to
determine their occurrence and characteristics. Thus, although the
respondents reported their perceptions of recent improvements in
awareness, they also stated that much more needs to be done in
order to improve both research and clinical practice in terms of detect-
ing, reporting, and averting negative effects.
Progress monitoring
Deterioration is difficult to distinguish based on clinical judgement
alone, and evidence suggests that clinicians are often poor at recog-
nising if a patient has worsened.15 Introducing some form of pro-
gress monitoring has therefore been proposed as a more accurate
way of identifying those who do not improve, with several studies
providing evidence for its superiority.16 Basically, progress
monitoring employs statistical and actuarial procedures to deter-
mine if a patient deviates from an expected trajectory. If that is
the case, the clinician or researcher will be notified in order to
ensure that the correct actions are implemented, for example con-
sidering other treatment alternatives. This type of notification has
not been found to boost effects or cut costs, rather, the advantages
seem to be lower rates of deterioration and non-response among
patients receiving treatment.17 Using data from progress monitor-
ing could also make it possible to explore what factors might be
responsible for worsening and lack of change. This should, in
turn, help improve how psychotherapy is being delivered as well
as increase the understanding of what actually constitutes function-
ality and dysfunctionality with regard to a patient’s mental health.
Qualitative methods
An increase in existing symptoms (i.e. deterioration) is probably the
most straightforward way of exploring negative effects of psycho-
therapy. However, different qualitative methods for investigating
other harmful events also exist. Interviews or self-report measures
may facilitate an in-depth exploration of detrimental effects, such
as asking patients to describe negative experiences during treatment,
similar to the use of open-ended questions in a recent study of
cognitive–behavioural therapy delivered via the internet.18 Further-
more, several instruments for assessing potentially harmful events
during treatment have recently been proposed, such as, the
Negative Effects Questionnaire,10 which could be useful for deter-
mining the relationship between adverse and unwanted events
and treatment outcome. Presently, qualitative methods are seldom
used in relation to negative effects but have been put forward as a
way of improving the understanding of their occurrence and
characteristics.19
Weaknesses
Definitions
Negative effects of psychotherapy presently lack a clear and coher-
ent terminology, possibly restricting the monitoring and reporting
of their incidence. Various propositions with regard to definitions
and consistency of terms have been proposed,7,19,20 but no consen-
sus currently exists as to what events need to be explored. Most
terms involve the exacerbation of symptoms or new forms of dis-
tress, but incidents of malpractice might also be important to con-
sider. In addition, it is not evident what distinguishes some negative
effects, such as, deterioration, from non-response or unmet treat-
ment expectations, which might be just as detrimental to the
patient. Furthermore, even in relation to worsening, which relies
on a statistical procedure such as the RCI, it not yet apparent if
this corresponds to a negative experience that happened during or
was caused by psychotherapy.21 Also, ceiling effects prevent patients
from deteriorating indefinitely during treatment. Although a recent
individual patient meta-analysis found that only 1.9% of 2866
patients were close to hitting the ceiling, there might be particular
patient groups where this risk is much higher.22 Likewise, increase
in symptomatology may reflect deterioration within one domain,
but it has been suggested that both improvement and worsening
could be made up of several distinct areas of functioning, such as
interpersonal problems, quality of life, and family distress.23
Hence, several issues need to be addressed in the future in order
to improve the monitoring and reporting of negative effects, both
in terms of their definitions and clinical significance.
Time period
The study of negative effects is highly influenced by the time period
during which they are being evaluated. However, deterioration and
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other potentially harmful events havemostly been determined on one
single occasion, making it unclear if they are transient or enduring.
Many patients may experience situations in treatment as negative
because they result in unwanted feelings or thoughts that have previ-
ously been avoided, even though it might be beneficial in the long
run, such as gradual exposure to certain stimuli in anxiety
disorders.24 Thus, without the use of a follow-up assessment it is
uncertain how incidents such as deterioration are associated with
long-term treatment outcome.22 Also, investigating other types of
negative effects solely after treatment has ended, for instance, by dis-
tributing open-ended questions or self-report measures, are highly
susceptible to the effects ofmemory bias and social desirability, affect-
ing the validity of the responses. Exploring negative effects at different
time points is therefore important to consider but has so far not war-
ranted sufficient attention among clinicians or researchers.
Perspective
Determining whether negative effects have occurred during treatment
largely depends on what perspective is endorsed. Incidents might, for
instance, be considered adverse and unwanted by a patient, but
deemed an inevitable part of certain interventions by a clinician.
Even results that are regarded as positive may potentially be viewed
as detrimental by others, as in the case of someone who becomes
more self-assertive towards relatives or co-workers. There may also
be a discrepancy between achieving good results in psychotherapy
but still not being satisfied by treatment outcome. The idea that the
benefits in psychotherapy could be perceived differently by the
patient and significant others is nothing new,25 but could be particu-
larly important in relation to negative effects as it is unclear if their
incidents can be attributed to treatment or other circumstances in
the patients’ lives. This might therefore warrant the implementation
of different perspectives in research and clinical practice, such as con-
sidering various types of information on progress.26 For instance, the
respondents discussed the possibility of exploring the positive as well
as negative effects of psychotherapy by interviewing significant others,
comparing clinician ratings to patient self-reports, and by distributing
an instrument specifically on negative effects to several parties. This
might, however, only be possible in certain research settings where
the patients consent to this type of investigation, and less so in clinical
practice.
Reporting
Negative effects are increasingly being reported in peer-reviewed
journals, even though far from every clinical trial includes this infor-
mation.12 However, the presentation of such incidents is not always
optimal, seldom including any details of how deterioration or
adverse or unwanted events were assessed. Editors therefore need
to become more aware of how negative effects can be monitored
and reported, and, possibly, also making it mandatory for research-
ers to include data of their occurrence as secondary analyses, similar
to exploring moderators of treatment outcome. Given the limited
space in peer-reviewed journals, it is understandable that the inves-
tigation of negative effects is often left out, but alternatives for their
inclusion and distribution should be possible. For instance, by pro-
viding supplementary material online, or, as in the case of studies
funded by the National Health Service in the UK, including a mon-
itoring system that can end a treatment prematurely if harm is
observed.
Opportunities
Effective methods
Promising methods for monitoring and preventing negative effects
already exist, such as progress monitoring by distributing self-report
measures at each session. This has been shown to improve the detec-
tion of deterioration, which can help to reverse a negative treatment
trend and minimise harm in psychotherapy.16 Additional research
needs to be performed in more settings and across different
samples in order to establish its benefits in clinical practice.
Particularly, studies need to be done in larger samples to increase
statistical power and preferably where the feedback measure is dif-
ferent from the one assessing treatment outcome. However, this is
only relevant for studying deterioration, as adverse and unwanted
events cannot be captured by this method. Yet, given the ease of
implementation and its possibility to determine worsening, progress
monitoring could be seen as a first, but not the only step in making
the assessment and investigation of negative effects an integral part
of clinical practice and research.
Informed consent
Based on the current understanding, information about both the
expected results and potential negative effects should be conveyed
to all patients before commencing treatment. Thereby, the risk of
deterioration and experiencing adverse and unwanted events can
be discussed carefully, possibly preventing or at least minimising
the impact of such events. Moreover, addressing the issue of nega-
tive effects early on could also help explore the expectations or idio-
syncratic beliefs the patient can have, such as, not wanting to
experience uncomfortable feelings or having unrealistic ideas
about treatment outcome. Both the pros and cons of treatment
should thus be reviewed, allowing the patient to make an informed
decision about whether to pursue psychotherapy or implement spe-
cific interventions. Although it has been shown that clinicians and
researchers are reluctant to mention possible risks of undergoing
treatment,27 it has not yet been established empirically that such
information induces harm or affects the therapeutic relationship.
Providing the patient with all necessary details regarding both
the advantages and disadvantages of undergoing psychotherapy
should therefore always be addressed during the informed
consent process.
Naturalistic designs
Negative effects are often explored within the context of clinical
trials that are performed in highly controlled settings. Even if this
is important to increase internal validity, it is also necessary to inves-
tigate harmful events in routine care. Practice-oriented research
conducted in the natural environment of the clinician could poten-
tially yield valuable information regarding the occurrence and
characteristics of deterioration, non-response and adverse and
unwanted events among patients receiving psychotherapy in a clin-
ical setting. For instance, a recent naturalistic study indicated that
more than half of the patients did not change reliably, and that a
larger proportion deteriorated in a psychiatric context (6.9%) com-
pared with primary care (1.8%).28 Using data from such research
could help pinpoint certain interventions as harmful and how it
has an impact on the therapeutic relationship, as well as facilitate
an investigation of how the occurrence of negative effects differ
between clinicians, such as, a higher probability of deterioration
among patients in comparison with colleagues.29
Threats
Reluctance
Despite many advantages of assessing negative effects in psycho-
therapy, clinicians and researchers are often reluctant to implement
effective methods. In particular, systems for tracking patients’ status
(i.e. progress monitoring) might be perceived as threating as the
information is forwarded to the treatment provider, increasing
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accountability. Being unaware of how such information is used
could make many clinicians insecure of its implementation, espe-
cially if it is used to compare colleagues with each other or to
blame an inferior treatment outcome on a specific clinician. In
the long run this might lead to a situation where the more severe
patients are referred elsewhere. Also, the costs of introducing mon-
itoring systems may inhibit its administration, both in terms of the
money required to set it up in routine care and research settings, and
the time it will require for clinicians and researchers to adjust to new
procedures and input relevant data.
Lack of knowledge
Clinicians and researchers are becoming increasingly aware of
the issue of negative effects in psychotherapy. Nonetheless, far
from everyone knows that there exist potential risks and not all
seem to agree on their characteristics.30 In addition, it can also be
assumed that somemight even perceive negative effects as necessary
in order to produce a positive treatment outcome (i.e. the need for
the patient to feel worse before feeling better). However, dissemin-
ating research on negative effects in routine care is difficult given the
workload in most settings, and there are countries where it is not
required by clinicians to be updated on the latest findings as part
of their professional practice. Furthermore, many researchers are
still unaware of detrimental effects in psychotherapy despite the
fact that it has been the topic of great debate for many years. Lack
of knowledge concerning negative effects therefore poses one of
the greatest threats to the monitoring and reporting of their
incidence.
Expectations
Investigating and informing about negative effects is considered
important. However, there is also a possibility that it could affect
the expectations of the patient. By putting too much emphasis on
the risks of psychotherapy this might interfere with the expectations
of getting better by undergoing treatment. In addition, focusing on
reducing experiences that can be perceived as negative by the patient
could potentially also interfere with certain parts of the interven-
tions that are in fact beneficial (i.e. avoiding the confrontation of
specific themes). Moreover, using the same researcher to investi-
gate both the positive and negative effects might introduce some
bias, for example the risk of patients’ not reporting harm in an
otherwise successful treatment, which should warrant methodo-
logical considerations as to how the implications of psychotherapy
are explored.
Discussion
In this study we have summarised current understanding and iden-
tified future research directions of monitoring and reporting of the
negative effects of psychotherapy by asking a select group of
researchers in the field to share their perceptions of these topics.
Everyone agreed that the awareness of the risks involved in treat-
ment have increased recently. However, a number of obstacles
were also proposed, including the lack of a clear and coherent ter-
minology, methodological issues and problems related to reporting
negative effects in many scientific journals. These results are in line
with the two recent editorials and a cross-sectional survey published
in the British Journal of Psychiatry,2–4 suggesting that more needs to
be done with regard to how clinicians and researchers study and
report events in treatment that are negative. Particularly, a consen-
sus on definitions would be valuable, as it might lead to a more sys-
tematic approach to exploring negative effects of psychotherapy (i.e.
assessing the same type of incidents). Furthermore, several aspects
related to the methodology being used also need to be agreed
upon, for example, the time period that deterioration should be
studied to determine if it is transient or enduring, and what perspec-
tives to consider, for example the patient, clinician or significant
others. Using naturalistic designs and qualitative methods could
also prove to be important, as it might reveal factors related to wor-
sening and adverse and unwanted events, as well as how patients
themselves perceive potentially harmful events in psychotherapy.
Meanwhile, both clinicians and researchers need to be informed
about the possibility that treatments are not without risks, especially
since prior evidence implies that clinical training seldom includes
information about negative effects.11 This could become an integral
part of their training, similar to teaching the basics of a particular
therapeutic orientation or the ethics and jurisdiction involved in
providing healthcare. In addition, informing patients about the ben-
efits as well as risks of psychotherapy should be seen as mandatory
during the informed consent process, allowing patients to make an
educated decision on whether or not to pursue treatment or imple-
ment certain interventions.
As for research practices, editors of scientific journals could
demand the reporting of negative effects prior to a potential publi-
cation, either as secondary analyses included in a manuscript or
accessible as supplementary material offered online. Given the
lack of consensus about how to define potentially harmful events,
using the RCI to determine reliable deterioration of symptomatol-
ogy could be a possible first step, as well as the inclusion of open-
ended questions regarding negative experiences among the patients.
Finally, progress monitoring is regarded as an effective method for
preventing deterioration and should become more widely used in
routine care as well as research settings.
However, a number of issues need to be resolved with regard to
accountability and how the information such a procedure provides
is going to be used, for example becoming liable for patient worsen-
ing. Furthermore, apart from an increase in symptomatology, other
dimensions of functionality may be important to consider in rela-
tion to treatment outcome, for instance, more global measures of
well-being. Nonetheless, monitoring treatment progress on a
session-by-session basis is seen as a promising way of minimising
the risk of deterioration in psychotherapy, as well as being useful
for the exploration of likely mechanisms responsible for negative
effects.
Limitations
The present commentary summarises the results and experiences of
investigating negative effects in psychotherapy made by a select
group of researchers in the field. As such, it provides valuable
insights with regard to the many methodological issues and prac-
tical difficulties involved in monitoring and reporting potentially
harmful events in treatment. However, given the lack of a systematic
approach and recruiting a limited number of researchers in the field
the results that have been presented should not be seen as exhaustive
or an attempt to cover all aspects on this topic. In addition, by not
including clinicians, there is also a risk of missing important aspects
related to negative effects in psychotherapy, such as working with
particular patient groups. Therefore, additional perspectives on
the subject of negative effects of psychotherapy most certainly
exist and might have emphasised a different set of issues than
those that have been put forward, limiting the generalizability of
the results. Furthermore, the use of an anonymous survey may
perhaps have prevented conformity and social inhibition, allowing
the researchers to more freely express their opinions and
comment on each other. However, given the novelty of administer-
ing SWOT for exploring a particular topic in psychotherapy, it is
unknown if other means would have revealed different results.
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Similarly, given the approach used, the results were not coded or
analysed according to the steps usually employed in, for example,
thematic analysis. This makes the issues of credibility and transfer-
ability as referred to in qualitative studies less clear, and should be
regarded as a limitation when interpreting the results. The conclu-
sions should therefore by no means be seen as definitive, but rather
as a reflection of how negative effects are currently being researched
and how it can be improved further in the future.
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Appendix
Survey
Write your response to the four SWOT questions below. The survey
is anonymous. You can be as brief or elaborate as you wish, using the
concepts of Strengths, Weaknesses, Opportunities and Threats in
relation to negative effects of psychological treatments.
1. Strengths: What are we doing well in terms of investigating the
occurrence and characteristics of negative effects? What
resources can we draw on? Strengths can refer to quality and reli-
ability, reflecting aspects to capitalise on, e.g., ‘Using the Reliable
Change Index as a measure of deterioration in clinical trials’.
2. Weaknesses: What could we improve with regard to examining
the occurrence and characteristics of negative effects? What
factors might be seen as limitations? Weaknesses can refer to
absence of strengths or aspects that may be turned into strengths
or need to be solved, e.g., ‘Inconsistencies in reporting deterior-
ation rates and adverse events in clinical trials’.
3. Opportunities: What opportunities are currently open in study-
ing the occurrence and characteristics of negative effects? What
trends could we take advantage of? Are there any identified
strengths that we could turn into opportunities? Opportunities
can refer to needs that are not yet addressed or must be acted
upon, e.g., ‘Systematically collecting patient-level data in clinical
trials to facilitate an inspection of predictors for deterioration
across psychological treatments’.
4. Threats: What threats could limit or become an obstacle for
researching the occurrence and characteristics of negative
effects? Are there any identified weaknesses that might become
threats? Threats can refer to events or forces that need to be
planned for, e.g., ‘Lack of knowledge among clinicians and
researchers with regard to monitoring and reporting negative
effects of psychological treatments’.
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